Fig. 2S
Comparison of FCRL1, 2, and 4 expressions in different age subgroups of Hashimoto's thyroiditis (HT) and Graves' disease (GD) patients with corresponding controls. FCRL2 revealed significantly higher expression in all four age subgroups of GD, but only in the two younger subgroups of HT. We observed significant overexpression of FCRL4 in the two younger subgroups of GD patients. The data are presented as median fold changes in mRNA levels. Although no significant difference was shown in FCRL1 expression between HT and GD patients, significant differences were found in FCRL2 and 4 expressions between the two groups. *** p <0.001. 
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